No abstract available
MeSH terms
-
Adult
-
Anti-Bacterial Agents / therapeutic use
-
Anti-Inflammatory Agents / therapeutic use
-
Combined Modality Therapy
-
Escherichia coli Infections / diagnosis
-
Escherichia coli Infections / microbiology
-
Escherichia coli Infections / therapy*
-
Escherichia coli O157* / pathogenicity
-
Female
-
Hemolytic-Uremic Syndrome / etiology
-
Hemolytic-Uremic Syndrome / prevention & control
-
Hemolytic-Uremic Syndrome / therapy
-
Humans
-
Plasma Exchange
-
Platelet Aggregation Inhibitors / therapeutic use
-
Prognosis
-
Renal Dialysis
-
Shiga Toxin 1 / biosynthesis
-
Shiga Toxin 1 / toxicity
-
Shiga Toxin 2
-
Shiga Toxins / biosynthesis
-
Shiga Toxins / toxicity
Substances
-
Anti-Bacterial Agents
-
Anti-Inflammatory Agents
-
Platelet Aggregation Inhibitors
-
Shiga Toxin 1
-
Shiga Toxin 2
-
Shiga Toxins
-
verocytotoxin 2